Kinsale Capital Group, Inc. (KNSL) Stock Price & Analysis
Kinsale Capital Group, Inc. (KNSL) fell 2.56% to USD 373.17 as of September 8, 2026 at 04:22 UTC, according to Nexqual real-time market data.
KNSL last closed at USD 373.17; the session ranged USD 372.83–380.39 on volume of 116,379 shares. Market capitalization is —, with a 52-week range of USD 287.2–485 (NYQ). Source: Nexqual, September 8, 2026 at 04:22 UTC.
Key Statistics (as of September 8, 2026 at 04:22 UTC)
| Price | USD 373.17 |
|---|---|
| Change | ▼ 2.56% (down) |
| Previous Close | USD 373.17 |
| Open | USD 373.17 |
| Day Range | USD 372.83 – 380.39 |
| 52-Week Range | USD 287.2 – 485 |
| Volume | 116,379 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (KNSL)
Nexqual's technical model rates KNSL "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 04:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 52.09 (neutral) |
| vs SMA50 | Above (USD 360.47) |
| MACD | 5.13 (positive) |
Financial Health Score (KNSL)
Nexqual rates Kinsale Capital Group, Inc.'s overall financial health "Strong" across five dimensions, as of September 8, 2026 at 04:22 UTC.
| Growth | Strong — Revenue +18% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 31% |
| Balance Sheet | Solid — $211M cash vs $225M debt |
| Cash Flow | Strong — FCF $982M, 52% margin |
| Efficiency | Strong — ROE 30%, ROA 7.6% |
From Kinsale Capital Group, Inc.'s Latest SEC 10-K Filing (filed 2026-02-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Using our proprietary technology platform and leveraging the expertise of our highly-experienced employees in our daily operations, we have built a company that is entrepreneurial and highly efficient.
- We believe that the combination of our proprietary technology platform and our expense management allows us to process quotes, underwrite policies and operate with a substantial cost advantage over our direct competitors.
- We use our proprietary technology platform to drive a high level of efficiency, accuracy and speed in our underwriting and quoting process.
- We have built a proprietary technology platform that reflects the best practices our management team has learned from its extensive experience.
Partnerships
- Our investment policy is designed to comply with the regulatory investment requirements and restrictions to which our insurance subsidiary is subject.
- Trade Representative announced their intention to exercise their authority under the Dodd-Frank Act to negotiate a "covered agreement" with the European Union (the "Covered Agreement").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WD | Walker & Dunlop, Inc | USD 42.61 | ▲ 6.34% |
| LOB | Live Oak Bancshares, Inc. | USD 39.61 | ▲ 0.25% |
| MEDP | Medpace Holdings, Inc. | USD 591.29 | ▼ 0.29% |
| FLGT | Fulgent Genetics, Inc. | USD 19.73 | ▼ 1.55% |
| APPN | Appian Corporation | USD 38.37 | ▼ 3.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:22 UTC. This page is informational and not investment advice.